1. Home
  2. WFF vs IMNN Comparison

WFF vs IMNN Comparison

Compare WFF & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WF Holding Limited Ordinary Shares

WFF

WF Holding Limited Ordinary Shares

N/A

Current Price

$0.44

Market Cap

9.3M

ML Signal

N/A

Logo Imunon Inc.

IMNN

Imunon Inc.

N/A

Current Price

$3.17

Market Cap

11.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WFF
IMNN
Founded
1984
1982
Country
Malaysia
United States
Employees
138
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3M
11.0M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
WFF
IMNN
Price
$0.44
$3.17
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$182.61
AVG Volume (30 Days)
514.7K
22.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.37
52 Week High
$29.22
$9.32

Technical Indicators

Market Signals
Indicator
WFF
IMNN
Relative Strength Index (RSI) 53.29 45.08
Support Level $0.38 $3.03
Resistance Level $0.52 $4.26
Average True Range (ATR) 0.06 0.22
MACD 0.02 0.02
Stochastic Oscillator 38.71 27.36

Price Performance

Historical Comparison
WFF
IMNN

About WFF WF Holding Limited Ordinary Shares

WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: